Search

everythinglearnresearchcommunity

for

Search:↓

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Stem cell serum effectively treated hair loss caused by COVID-19.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Oral and topical finasteride are effective and safe for treating female hair loss.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

2% topical minoxidil effectively treats female hair loss with minimal side effects.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Women with female pattern hair loss have lower Vitamin D3 levels.

Low levels of vitamin B12 and ferritin are linked to early hair graying.

Women with androgenetic alopecia have lower zinc and iron levels.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Women losing hair might have lower levels of vitamin D.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

Many dermatologists in India find serum peptide formulations effective for treating hair loss.

Low PON1 levels may indicate and predict the severity of hair loss.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.